Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the health-check domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /dom76025/wp-includes/functions.php on line 6121
Reviewing the New Data on Topical Roflumilast in Scalp and Body PsO, Seb Derm, and AD in Patients With Diverse Skin Types - The Dermatology Digest
Subscribe
Search

Reviewing the New Data on Topical Roflumilast in Scalp and Body PsO, Seb Derm, and AD in Patients With Diverse Skin Types

Patrick Burnett, MD, PhD, Chief Medical Officer of Arcutis Biotherapeutics, reviews new data on the use of topical roflumilast (Zoryve) in scalp and body psoriasis, seborrheic dermatitis, and atopic dermatitis in patients with diverse skin types presented at the 2024 Fall Clinical Dermatology Conference in Las Vegas, NV. Dr. Burnett also discusses the ongoing topical renaissance in inflammatory skin diseases.

Print Friendly, PDF & Email